最新试用


EudraCT Number: 2004-000530-37 Sponsor Protocol Number: 24978 Start Date: 2004-09-16
Sponsor Name: Serono International S.A.
Full Title: A multicentre, randomised, double blind, placebo controlled phase III study of subcutaneously administered onercept in the initial treatment and continued treatment after extended therapy in subjec...
Medical condition: Psoriasis is an inflammatory skin disorder that affects between 1 and 2% of the population. It is characterised by an increased proliferation of the epidermis, and presents as well-defined thickene...
Disease: Version SOC Term Classification Code Term Level
7.0 10037153 PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: LT (Completed) LV (Completed) EE (Completed)
Trial results: View results

EudraCT Number: 2004-001662-41 Sponsor Protocol Number: BAP00154 Start Date: 2004-09-16
Sponsor Name: Basilea Pharmaceutica Ltd
Full Title: A Phase III, Randomized, Double-Blind Study of Ceftobiprole versus Vancomycin in the Treatment of Complicated Skin and Skin Structure Infections
Medical condition: Complicated skin and skin structure infections
Disease: Version SOC Term Classification Code Term Level
LLT 10024768 code
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: LT (Completed) LV (Completed) HU (Completed) IT (Completed)
Trial results: View results
EudraCT Number: 2004-001730-17 Sponsor Protocol Number: BAP00248/307 Start Date: 2004-09-16
Sponsor Name: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Full Title: A Phase 3, Randomized Double-Blind Study of Ceftobiprole Medocaril Versus Linezolid Plus Ceftazidime in the Treatment of Nosocomial Pneumonia
Medical condition: Nosocomial Pneumonia
Disease: Version SOC Term Classification Code Term Level
9.1 10052596 Nosocomial pneumonia LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: LT (Completed) LV (Completed) HU (Completed) GB (Completed) ES (Completed)
Trial results: View results

EudraCT Number: 2004-001069-17 Sponsor Protocol Number: CSPI135ZDE04 Start Date: 2004-09-16
Sponsor Name: Novartis Pharma GmbH
Full Title: A double-blind, active-controlled, randomized, multicenter, parallel-group 2 day comparison of 1000 mg propyphenazone / 80 mg codeine (applied as two suppositories) combination therapy versus a 100...
Medical condition: acute, at least moderate to severe biliary or urogenital pain
Disease: Version SOC Term Classification Code Term Level
7.0 10004670 low
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: LT (Completed)
Trial results: View results
EudraCT Number: 2004-001648-64 Sponsor Protocol Number: No EP-24332T-A014 Start Date: 2004-09-16
Sponsor Name: ardana LTD
Full Title: A Phase II multicentre, open-label study investigating the pharmacokinetics, pharmacodynamics, efficacy and safety of a loading dose regimen of a new GnRH antagonist, Teverelix 90 mg, long-acting f...
Medical condition: advanced prostate cancer
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male
Trial protocol: LT (Completed)
Trial results: (No results available)

EudraCT Number: 2006-001217-15 Sponsor Protocol Number: 85/04/04 Start Date: 2004-09-16
Sponsor Name: Lassila Riitta
Full Title: PRO-FEIBA. Asetelma on selkeä etenevä satunnaistettu kaksisuuntainen tutkimus aktivoitujen hyytymistekijöiden (aPCC, activated prothrombin complex concentrate) vaikutuksesta vaikeaa A hemofiliaa sa...
Medical condition: A-hemofilia
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Adolescents, Under 18, Adults Gender: Male
Trial protocol: FI (Ongoing)
Trial results: (No results available)
EudraCT Number: 2004-001590-26 Sponsor Protocol Number: MAS QUE NADA Start Date: 2004-09-15
Sponsor Name: OSPEDALE S. RAFFAELE
Full Title: NATIONAL, MULTICENTER, RANDOMIZED,OPEN STUDY TO EVALUATE EFFICACY AND SAFETY OF LAMIVUDINE (300 MG QD) MONOTHERAPY AS AN ALTERNATIVE TO THERAPEUTIC INTERRUPTION IN PAZIENTS AFFECTED BY HIV-1, IN VI...
Medical condition: HIV MONOTHERAPY TREATMENT , AS THERAPEUTIC MAINTENANCE, DURING INTERRUPTION OF ANTIVIRAL THERAPY
Disease: Version SOC Term Classification Code Term Level
6.1 10021428 SOC
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Prematurely Ended)
Trial results: View results

EudraCT Number: 2004-000050-23 Sponsor Protocol Number: 28130 Start Date: 2004-09-15
Sponsor Name: NV Organon
Full Title: Prospective, double-blind, randomized, placebo-controlled dose finding study of the efficacy and safety of 2 target doses of Org 34517 used as adjunctive therapy in subjects with psychotic major de...
Medical condition: Psychotic major depression (major depressive episode, severe, with psychotic features)
Disease: Version SOC Term Classification Code Term Level
6.1 10037250 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: CZ (Completed) GB (Completed)
Trial results: View results
EudraCT Number: 2004-001827-39 Sponsor Protocol Number: SIFIM Start Date: 2004-09-15
Sponsor Name: OSPEDALE S. RAFFAELE
Full Title: NATIONAL, MULTICENTER, RANDOMISED, OPEN STUDY TO VALUATE THE EFFICACY OF DIFFERENT THERAPEUTIC STRATEGIES TO AVOID THE IMMUNOLOGIC FAILURE IN MULTIRESISTENT HIV-1 INFECTED PATIENTS.
Medical condition: HIV TREATMENT
Disease: Version SOC Term Classification Code Term Level
10010504 PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Prematurely Ended)
Trial results: View results

EudraCT Number: 2004-000638-35 Sponsor Protocol Number: CZOL446N2312 Start Date: 2004-09-15
Sponsor Name: Novartis Sverige AB
Full Title: A 2-year randomized, multicenter, double-blind, placebocontrolled study to determine the efficacy and safety of intravenous zoledronic acid 5 mg administered either annually at randomization and 12...
Medical condition: Postmenopausal Osteoporosis
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Female
Trial protocol: SE (Completed) ES (Completed)
Trial results: View results
3